(1)
Formulation and Evaluation of Extended-Release Bilayer Tablets Containing Empagliflozin and Metformin Hydrochloride for Diabetes Mellitus Management. Int. J. Pharm. Sci. Drug Res. 2024, 16 (5), 777-787. https://doi.org/10.25004/IJPSDR.2024.160505.